Dunsire Deborah has filed 13 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 301 shares of MCKESSON CORP ($MCK) on July 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 30, 2025 | MCKESSON CORP | $MCK | Dunsire Deborah | Director | A | Restricted Stock Units (RSUs) | 301 | $0.00 | 301.0000 | 280,000,000 | 9999.99% | 0.00% |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Dunsire Deborah | Not found | A | Common Stock | 5740 | $0.00 | 30,815.0000 | 90,538,118 | 22.89% | 0.01% |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Dunsire Deborah | Not found | A | Stock Option (Right to Buy) | 10787 | $0.00 | 10,787.0000 | 90,538,118 | 9999.99% | 0.01% |
| July 31, 2024 | MCKESSON CORP | $MCK | Dunsire Deborah | Director | A | Restricted Stock Units (RSUs) | 349 | $0.00 | 349.0000 | 279,000,000 | 9999.99% | 0.00% |
| June 18, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Dunsire Deborah | Not found | A | Common Stock | 5345 | $0.00 | 25,075.0000 | 73,543,862 | 27.09% | 0.01% |
| June 18, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Dunsire Deborah | Not found | A | Stock Option (Right to Buy) | 9900 | $0.00 | 9,900.0000 | 73,543,862 | 9999.99% | 0.01% |
| June 5, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Dunsire Deborah | Not found | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 28,325,779 | 9999.99% | 0.02% |
| June 5, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Dunsire Deborah | Not found | A | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 28,325,779 | 9999.99% | 0.01% |
| June 3, 2024 | MCKESSON CORP | $MCK | Dunsire Deborah | Director | A | Restricted Stock Units (RSUs) | 56 | $0.00 | 56.0000 | 278,000,000 | 9999.99% | 0.00% |
| June 1, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Dunsire Deborah | Not found | M | Common Stock | 4000 | $0.00 | 12,000.0000 | 28,325,779 | 50.00% | 0.01% |
| June 1, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Dunsire Deborah | Not found | M | Restricted Stock Units | 4000 | $0.00 | 0.0000 | 28,325,779 | 100.00% | 0.01% |
| June 7, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Dunsire Deborah | Director | A | Common Stock | 3860 | $0.00 | 19,730.0000 | 69,914,225 | 24.32% | 0.01% |
| June 7, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Dunsire Deborah | Director | A | Stock Option (Right to Buy) | 7110 | $0.00 | 7,110.0000 | 69,914,225 | 9999.99% | 0.01% |